Literature DB >> 18320517

Correlation of visual function impairment and OCT findings in patients with Stargardt disease and fundus flavimaculatus.

G Querques1, R Prato, C Iaculli, M Voigt, N Delle Noci, G Coscas, G Soubrane, E H Souied.   

Abstract

PURPOSE: To investigate the relationship between morphologic lesions of the retina and functional abnormalities in patients with Stargardt disease (STGD) and fundus flavimaculatus (FFM). DESIGN. Case-controlled, prospective, comparative observational study.
METHODS: A complete ophthalmologic examination, including best-corrected visual acuity (BCVA) and optical coherence tomography (OCT), was performed in 61 eyes of 32 consecutive patients with STGD/FFM and in 60 eyes of 30 matched healthy control subjects. Furthermore, fundus-related perimetry was performed in 12 of the affected eyes.
RESULTS: The age ranged from 21 to 71 years in STGD/FFM patients and from 21 to 72 years in controls. BCVA ranged from 20/20 to 20/400 and from 20/20 to 20/32, respectively, in STGD/FFM patients and in controls. A foveal thinning was found by OCT Stratus in almost all cases (average 160 microm) compared with controls (average 210 microm) (p<0.001). BCVA impairment significantly correlated to the degree of foveal thinning (r2=0.16; p=0.0014). Moreover, in STGD/FFM patients the authors observed two types of hyperreflective deposits which were not correlated with BCVA impairment or foveal thinning. In addition, fundus-related perimetry revealed a stable fixation in 8/12 eyes, that was predominantly central in only 4 of these eyes. A smaller degree of foveal thinning correlated to a more stable fixation (p=0.0108), even if not predominantly central (p=0.0218).
CONCLUSIONS: In this series, lower visual acuity and unstable fixation correlated with a greater transverse foveal thinning. OCT and fundus-related perimetry may be useful tools in STGD/FFM patients.

Entities:  

Mesh:

Year:  2008        PMID: 18320517     DOI: 10.1177/112067210801800212

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  7 in total

1.  Disruption in Bruch membrane in patients with Stargardt disease.

Authors:  Sung Pyo Park; Stanley Chang; Rando Allikmets; R Theodore Smith; Tomas R Burke; Emily Gregory-Roberts; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2011-11-07       Impact factor: 1.803

2.  ELLIPSOID ZONE MAPPING AND OUTER RETINAL ASSESSMENT IN STARGARDT DISEASE.

Authors:  Sruthi Arepalli; Elias I Traboulsi; Justis P Ehlers
Journal:  Retina       Date:  2018-07       Impact factor: 4.256

3.  Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.

Authors:  Artur V Cideciyan; Malgorzata Swider; Tomas S Aleman; Willam J Feuer; Sharon B Schwartz; Robert C Russell; Janet D Steinberg; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

Review 4.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

5.  Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.

Authors:  Yingming Chen; Kavitha Ratnam; Sanna M Sundquist; Brandon Lujan; Radha Ayyagari; V Harini Gudiseva; Austin Roorda; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

6.  Infrared scanning laser ophthalmoscope imaging of the macula and its correlation with functional loss and structural changes in patients with stargardt disease.

Authors:  Anastasios Anastasakis; Gerald A Fishman; Martin Lindeman; Mohamed A Genead; Wensheng Zhou
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

7.  In vivo visualization of photoreceptor layer and lipofuscin accumulation in stargardt's disease and fundus flavimaculatus by high resolution spectral-domain optical coherence tomography.

Authors:  Giuseppe Querques; Rosy Prato; Gabriel Coscas; Gisèle Soubrane; Eric H Souied
Journal:  Clin Ophthalmol       Date:  2009-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.